<unk>  is used to treat type 2 diabetes. It is generally less preferred than metformin or sulfonylureas. It is taken by mouth. It is also available as the fixed-dose combinations of<unk> /metformin (Janumet, Janumet XR) and<unk> /simvastatin (Juvisync).<unk>  should not be used to treat type 1 diabetes. In December 2020, the U.S. Food and Drug Administration (FDA) approved labeling changes stating that Januvia<unk> , Janumet<unk>  and metformin hydrochloride), and Janumet XR<unk>  and metformin hydrochloride extended-release) are not proven to improve glycemic (blood sugar) control in children aged 10 to 17 with type 2 diabetes. The drugs are approved to improve blood sugar control in adults aged 18 and older with type 2 diabetes.
Sitagliptin
Linagliptin
Vildagliptin
Saxagliptin
Liraglutide
Exenatide
Pioglitazone
Canagliflozin